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Abstract
Background: MenH (2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase) is a key enzyme in the
biosynthesis of menaquinone, catalyzing an unusual 2,5-elimination of pyruvate from 2-succinyl-5-enolpyruvyl-6-
hydroxy-3-cyclohexadiene-1-carboxylate.
Results: The crystal structure of Staphylococcus aureus MenH has been determined at 2 Å resolution. In the
absence of a complex to inform on aspects of specificity a model of the enzyme-substrate complex has been used
in conjunction with previously published kinetic analyses, site-directed mutagenesis studies and comparisons with
orthologues to investigate the structure and reactivity of MenH.
Conclusions: The overall basic active site displays pronounced hydrophobic character on one side and these
properties complement those of the substrate. A complex network of hydrogen bonds involving well-ordered
water molecules serves to position key residues participating in the recognition of substrate and subsequent
catalysis. We propose a proton shuttle mechanism, reliant on a catalytic triad consisting of Ser89, Asp216 and
His243. The reaction is initiated by proton abstraction from the substrate by an activated Ser89. The propensity to
form a conjugated system provides the driving force for pyruvate elimination. During the elimination, a methylene
group is converted to a methyl and we judge it likely that His243 provides a proton, previously acquired from
Ser89 for that reduction. A conformational change of the protonated His243 may be encouraged by the presence
of an anionic intermediate in the active site.
Background
Menaquinone, vitamin K2, is a lipid soluble quinone
used by bacteria for electron transport. It is the sole qui-
none available to Gram-positive bacteria [1] whereas
Gram-negative bacteria use ubiquinone under aerobic
conditions, and menaquinone under anaerobic condi-
tions [2]. Vitamin K, as menaquinone or the plant form
phylloquinone, is a cofactor for g-carboxylation of gluta-
mate, a post-translational modification of proteins
involved in blood coagulation and vascular biology and
is an essential component of the mammalian diet [3].
There are two distinct biosynthetic routes to menaqui-
none. One, recently discovered, occurs in a small subset
of bacteria such as Helicobacter pylori [4]. The starting
point is chorismate supplied by the Shikimate pathway
and the intermediates include the inosine derivative
futalosine. The most prevalent, classical biosynthetic
route to menaquinone, has been most studied in
Escherichia coli [1]. The starting point remains choris-
mate, which is isomerized to isochorismate then con-
verted, in three enzyme-catalyzed stages, to o-succinyl-
1-benzoate. Two further reactions, involving ATP and
CoA, lead to a CoA-naphthalene derivative before a
thioesterase [5] removes the CoA moiety to release 1,4-
dihydroxy-2-napthanoate. Prenylation, with products
from the isoprenoid biosynthesis pathway, and finally a
methylation reaction completes the production of
menaquinone.
To attain a comprehensive understanding of menaqui-
none biosynthesis, a fundamental aspect of bacterial
metabolism, it is imperative to characterize the molecu-
lar structures and properties of the relevant enzymes.
Our research in this area is confined to the classical
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reported on MenB [6] and MenD [7,8]. We turn our
attention now to MenH, the enzyme which catalyzes the
third step in this pathway, a 2,5-elimination of pyruvate
from 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexa-
diene-1-carboxylate (SEPHCHC) to produce 2-succinyl-
6-hydroxy-2,4-cyclohexadiene-1-carboxylate (SHCHC,
Figure 1).
There has been confusion about the reaction catalyzed
b yM e n H ,i nl a r g ep a r td u et om i s a s s i g n m e n to ft h e
enzymatic activities of MenB and MenD. Initial reports
[9] described MenD as the enzyme that cleaved the pyr-
uvate side chain from the isochorismate - a-ketogluta-
rate adduct SEPHCHC. MenB was assumed to cyclize
and then cleave CoA from a napthanyl derivative [10],
a n dt h ep r o d u c te n c o d e db yt h emenH gene had no
function assigned. It was subsequently proven that
MenB lacked such CoA esterase activity and then postu-
lated that MenH could catalyze this reaction [1]. Indeed,
many databases still list menH as encoding a thioester-
ase. More recently, Jiang et al. [11] showed that MenD
is not a bifunctional enzyme but is SEPHCHC synthase
[E.C. 2.2.1.9]. Structural and kinetic studies are compati-
ble with this assignment [7,8]. Rigorous biochemical
analysis then proved that MenH is actually responsible
for the elimination of the pyruvate side chain (E.C.
4.2.99.20) and that previous studies had been compro-
mised by the inherent reactivity of SEPHCHC, which
slowly decomposes to SHCHC and pyruvate [12].
We now describe the high-resolution crystal structure
of Staphylococcus aureus MenH (SaMenH), compare it
to the structure of the Vibrio cholerae enzyme
(VcMenH) deposited in the Protein Data Bank (PDB)
and discuss conserved residues with particular focus on
what such residues contribute to the architecture of the
active site. Consideration of data derived from site-
directed mutagenesis and kinetic studies of the E. coli
enzyme (EcMenH) [12,13] allow us to reassess the mole-
cular features that influence specificity and reactivity of
MenH and address two issues of the structure-mechan-
ism relationship, which remain unclear. The assignment
of an oxyanion-binding site formed by two amino acid
side chains by Jiang et al. [13] is highly unusual and is
revisited. Finally the origin of the proton that converts a
methylene group to a methyl (Figure 1) is considered
and a proton-shuttle mechanism, involving transfer
from substrate to protein then back at a different posi-
tion is proposed.
Results and Discussion
General comments and overall structure
An efficient bacterial expression system for a histidine-
tagged SaMenH was constructed and supplied material
for structural studies. Approximately 40 mg of protein
was obtained from 1 L of E. coli culture. The enzyme
crystallizes in the monoclinic space group C2w i t ho n e
molecule in the asymmetric unit and diffraction data to
better than 2 Å were measured in-house. The structure
was solved by molecular replacement using a model
based on PDB entry 1r3d, which although listed as a
protein of unknown function from V. cholerae, has been
identified as MenH [12]. The sequence identity with
SaMenH is about 20% and the best molecular replace-
ment solution had a translational Z-score of 6.4, low for
a correct solution. The initial electron and difference
density maps were of poor quality but with defined
Figure 1 The reaction catalyzed by MenH. Figures 1 and 7 were prepared with Chemdraw (Adept Scientific).
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solution had been obtained. Analysis of molecular pack-
ing in the crystal lattice also engendered confidence in
the solution therefore we proceeded with refinement.
The maps gradually improved with rounds of careful
model building and refinement. Once all ordered MenH
residues were included in the model a search for water
molecules, to be included in the refinement, was
initiated. A conservative approach to water identification
was adopted. The crystallographic statistics and model
geometry indicate that the refinement has produced an
acceptable high-resolution model (Table 1). At the end
of the refinement there was continuous electron density
for the entire polypeptide chain, residues 1-266, missing
only the Gly-His residues that remain at the N-terminus
following proteolytic cleavage of the histidine tag.
Approximately 65% of the SaMenH residues are in
well-defined elements of secondary structure. These
comprise 7 b-strands and 11 a-helices arranged in the
a/b hydrolase fold [14,15], a central b-sheet with a
marked twist, sandwiched between a-helices (Figure 2).
Strand b1 is antiparallel to the others. Helices a1a n d
a11 lie in the concave face of the b-sheet and a4t oa8
form an insertion in the canonical a/b hydrolase fold to
create a domain that caps the active site. The interface
between the cap and core domains, which involves 11
hydrogen bonds, occludes approximately 25% of the
surface area of the cap domain itself (~1500 Å
2 of
~5900 Å
2).
Members of the a/b hydrolase family display different
oligomerization states. For example, the C-C bond
hydrolase MphC is dimeric in both solution and crystal-
line states, with an extended b-sheet formed across the
dimer interface [16] whilst others such as acetylcholine
esterase are monomeric [17]. SaM e n Hb e h a v e sa sa
monomer in solution, as indicated by size-exclusion
chromatography (data not shown). Analysis of the crys-
tal structure using the Protein Interfaces, Surfaces and
Assemblies server [18] indicated no significant areas of
interaction to suggest oligomerization of MenH in the
crystalline state (data not shown).
Comparisons with related structures
There are over 660 structures known for a/b hydro-
lase family members and they encompass a wide range
of differing functions such as esterases, hydrolases,
lipases, haloperoxidases and peptidases [14,17,19]. The
fold is tolerant to insertions, with proteins ranging
from 200 to 600 residues in length. The canonical a/b
hydrolase structure contains a core composed of eight
b-strands [14,15]. However, in SaMenH the core b-
sheet consists of only seven strands due to the
absence of the N-terminal strand observed in other
family members. A common insertion in the canonical
a/b hydrolase fold is a lid, or cap domain over the
active site. In SaMenH the cap is formed by five
helices, a4t oa8 (Figure 2). The cap domain is impor-
tant in defining the active site size and aspects of sub-
strate specificity as will be described. In some
structures the cap domain appears to be flexible as
Table 1 Crystallographic statistics
Resolution range (Å) 19.73 - 1.94
Unit cell dimensions a,b,c (Å) b (°) 76.6, 43.6, 71.7, 98.3
Space group C2
No. reflections measured, unique 71,206, 17.242
Multiplicity
a , Completeness (%) 4.1(3.3), 98.9 (93.3)
Wilson B (Å
2) 24.5
Rmerge(%)
b , < I/?(I) > 5.3 (37.3), 17.5 (3.2)
Protein residues, water molecules 266, 185
Rwork(%)
c , Rfree(%)
d 18.3, 24.1
DPI (Å)
e 0.18
Average B-factors (Å
2)
Overall, main chain, side chain, waters 30.6, 29.3, 31.8, 31.3
R.m.s.d bond lengths (Å), angles (°) 0.012, 1.25
Ramachandran plot analysis (%)
Favorable, Outliers 97.7, 0
a.Values in parentheses refer to the highest resolution shell. 2.05 - 1.94 Å
b.
Rmerge = ∑hkl∑i|Ii(hkl) - < I(hkl)>|/ ∑hkl∑i Ii(hkl); where Ii(hkl) is the intensity of the
ith measurement of reflection hkl and < I(hkl)> is the mean value of Ii(hkl) for
all i measurements.
c. Rwork = ∑hkl||Fo|-|Fc||/∑|Fo|, where Fo is the observed
structure factor and Fc is the calculated structure factor.
d. Rfree is the same as
Rcryst except calculated with a subset, 5%, of data that are excluded from
refinement calculations.
e. DPI, Diffraction-component Precision Index [39].
Figure 2 The structure of SaMenH and position of the active
site. The polypeptide is depicted as a ribbon with helices of the core
domain colored red and b-strands blue, helices of the cap domain
are copper colored. N and C mark the amino and carboxy termini of
the protein. The catalytic triad consisting of Ser89, His243 and Asp216
are shown as sticks and mark the active site. Figures 2, 3, 4 and 6
prepared using PyMOL[41] and Illustrator (Adobe Systems Inc.).
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is not the case in SaMenH (data not shown) where we see
no correlation between the selected Translation-Libration-
Screw (TLS) domains and the cap/core domains. This
observation should be treated with caution since the
SaMenH crystals contain a relatively low volume of bulk
solvent (approximately 35%) and the molecular packing in
the crystal lattice involves direct interactions of residues in
the cap domain with three symmetry related molecules.
The tight packing may therefore artificially restrict flexibil-
ity of the cap domain with respect to the core of the
structure.
Analysis using Secondary Structure Matching [20] indi-
cates that, as expected, SaMenH is similar to various a/b
hydrolases. However, with the exception of VcMenH,
there are no particularly close matches in the PDB. The
structural homologues include haem-independent halo-
peroxidases, various esterases and hydrolases that over-
lay with SaMenH with root-mean-squared deviation
(r.m.s.d.) values in the range 2.0-2.4 Å, all with
approximately 230 aligned Ca atoms and sequence
identities around 20%. Similar results have been
reported in structural comparisons of the a/b hydro-
lases, for example in an investigation of the carboxylester-
ase BioH from E. coli [21]. Of note is the Rv0554 protein
from Mycobacterium tuberculosis recently investigated as
a potential MenH orthologue, which falls within the range
observed for the other a/b-hydrolases (r.m.s.d. 2.3Å for
overlay of 227 Ca positions) and has no activity with
SEPHCHC [22].
A closer alignment is observed when comparing
SaMenH with VcMenH, proteins which share 21%
sequence identity. The r.m.s.d. is 1.8 Å for least-
squares fit of 232 Ca atoms (Figure 3). The loop link-
ing b3a n da2, a region of high sequence variability in
MenH orthologues (data not shown), is not modelled
in the structure of VcMenH but is ordered in
SaMenH. The largest difference between the two
structures is in the orientation of the N-terminal
region of b7, part of the lid domain, where Ca posi-
tions differ by up to 4 Å (Figure 3). This overlay high-
lights similarities in and around the active site that are
likely important for enzyme activity and will be mentioned
in the next section.
The architecture of the MenH active site and recognition
of substrate
The residues that form the SaMenH catalytic triad,
Ser89, Asp216 and His243 are positioned on one side of
a water-filled tunnel formed between the cap and core
domains (Figure 4). The residues that contribute to the
active site are contributed from a4, a5, a8, a10, two
turns between b2-a1a n db4-a3 respectively and the
loops that follow b5a n db7 (Figure 2). The entrance to
t h ea c t i v es i t ei sn e a rA r g 1 2 7a n dt h et u n n e lt h e n
extends around and over the catalytic center to Asn32, a
distance of about 25 Å (data not shown). A complex
network of hydrogen bonds, involving well ordered
water molecules, serve to organize the residues around
the active site. The electrostatic properties complement
Figure 3 Overlay of SaMenH and VcMenH. A stereoview of the Ca trace of MenH from two species. SaMenH is depicted as a semitransparent
van der Waals surface (gray) with Ca trace as black sticks. The Ca trace of VcMenH is shown as red sticks.
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boxylate groups, at positions C1, C2, C5 and a hydro-
phobic component (Figure 1). A cavity is formed to the
side of this tunnel near Phe23, adjacent to the catalytic
machinery (Figure 4).
As is typical of the a/b hydrolase fold, the catalytic
serine (Ser89) occurs in a GXSXG motif (Figure 5)
located on a tight turn, often termed the ‘nucleophile
elbow’, between a central b-strand and a helix. The two
glycine residues help create the tight turn, which is also
stabilized by a hydrogen bond formed between the main
chain carbonyl of Ser89 and amide nitrogen of Gly92
(data not shown). Asp216 is located on a second tight
turn, between b6a n da10, and is shielded from the
active site by Leu155 and Phe219. The hydrogen bond-
ing interaction between Asp216 and His243, helps to
position the imidazole to interact with the hydroxyl of
Ser89 in the apo-structure. Ser89 OG also accepts a
hydrogen bond donated from a particularly well-ordered
water molecule (B =7Å
2, where B is the Debye-Waller
or isotropic temperature factor, 8π
2〈u
2〉 with u the
atomic displacement parameter), which in turn accepts
two hydrogen bonds from the main chain amides of
Phe23 and Met90.
Figure 5 A sequence alignment of SaMenH and EcMenH. Residues outlined in black are 90% conserved in 101 MenH sequences. Residues
outlined in grey are conserved in SaMenH and EcMenH. Residues marked with a star form the catalytic triad and those residues were mutated
by Jiang et al.[13] in EcMenH are marked with a triangle. This figure was prepared using MUSCLE [42] and ALINE [43].
Figure 4 Stereoview of the active site, catalytic triad and oxyanion-binding site. SaMenH is depicted as semi transparent van der Waals
surface colored according to atom type (C grey, N blue, O red, S yellow). Selected amino acid side chains are shown as sticks colored according
to atom type. The main chain of Met90 and Gly22-Phe23 are included to mark the oxyanion-binding site. Marine colored spheres represent
selected water molecules. Black dashed lines mark potential hydrogen bonding interactions, the C-H￿￿￿O interaction between Tyr88 and His243 is
represented by a dashed red line.
Dawson et al. BMC Structural Biology 2011, 11:19
http://www.biomedcentral.com/1472-6807/11/19
Page 5 of 11T h ea c t i v es i t eh a sap r o n o u n c e dh y d r o p h o b i cp a t c h
created by Trp150, Phe156, Leu153, Leu155 and
Phe219, and in addition Phe23 and Leu186 (not shown)
help form the base of the site (Figure 4). The position of
Trp150 is determined by van der Waals interactions
with Phe23 and Phe146 (not shown) on one side of the
indole, Phe156 on the other side and the side chain of
Arg134 abuts CZ3. This orientation of the Trp150 side
chain places NE1 directed towards the active site to
form a hydrogen bond with an ordered water molecule
(Figure 4) that contributes to forming a network of
solvent molecules in the active site. Phe219, Leu155 and
Phe156 provide a hydrophobic environment around the
side chain of His243 helping to hold it in place and pro-
viding a microenvironment that may increase the pKa.
The side chain of Tyr88 is positioned by van der Waals
interactions with Gly22 Ca,S e r 8 9C b,G l u 1 1 2C Da n d
His246 CE1. His246 is held in place by hydrogen bonds
f o r m e db e t w e e nN D 1a n dN E 2w i t hG l u 1 1 2O E 1a n d
Thr29 OG1 respectively (data not shown). As a result,
Tyr88 OH is placed to participate in hydrogen bonds with
Thr244 OG1 and an ordered water molecule, (B =1 8Å
2).
A distance of 3.2 Å separates His243 CD2 from Tyr88 OH
and the geometry is compatible with the presence of a
C-H￿￿￿O hydrogen bond (Figure 4) [23]. The C-H￿￿￿O
hydrogen bond is a weak interaction but may contribute
stability to the positive-charge distribution on the proto-
nated histidine and in so doing support a catalytic func-
tion. Such a role has been invoked in enzymes such as
trypanothione reductase, which is dependent on proton
transfer from histidine [24].
T h e r ea r es i xb a s i cr e s i d u e si nt h ea c t i v es i t e( A r g 9 3 ,
Arg127, Arg134, Arg174, Lys218 and the catalytic
His243) and a single acidic residue, Asp131 (Figure 4).
Lys218 is on the periphery of the active site with the ali-
phatic component of the side chain lying on the side
chain of Phe219. Arg127 and Arg134, together with
Asp131 are opposite Lys218. Arg127 forms both a direct
and a water-mediated hydrogen-bonding association
with Asp131, which also accepts a hydrogen bond from
Arg134. The water that bridges Arg127 and Asp131,
Wat15 (B =1 7Å
2) accepts a hydrogen bond donated by
the amide of Thr191. Arg93 is held in place by forming
a hydrogen bond to the main chain carbonyl of Tyr189
and to two water molecules in the active site, Wat22
(B =2 1Å
2)a n dW a t 4( B =2 2Å
2). Arg174 is about 10
Å from the catalytic center lining the polar tunnel
formed at the interface of the cap and core domains.
Arg174 NH2 donates a hydrogen bond to Gln159 OE1
and to four water molecules, two of which are shown in
Figure 4.
The overall sequence identity between MenH proteins
is relatively low and a comparison highlights key resi-
dues in and around the active site (Figure 5). Of 256
orthologues in the Kyoto Encyclopedia of Genes and
Genomes (KEGG) [25], 101 are unique when filtered at
a 90% sequence identity level. Within these sequences,
23 residues are conserved in at least 90% of them. The
catalytic triad is conserved in all but one sequence
where aspartate is replaced by glutamate. Eight of the
remaining strictly conserved residues are glycine, which
are all located at the end of secondary structure
elements or in loops and may be important in defining
the overall structure, for example in the “elbow” motif
in the active site. The acidic Asp131, five of the nine
hydrophobic residues and five out of the six basic resi-
dues listed above as contributing to the architecture of
the active site are strictly conserved. Three of the hydro-
phobic residues, Met90, Phe146, Leu155 are replaced by
valines or leucine. Arg134 is not a highly conserved
residue, being substituted by Trp131 in EcMenH for
example (Figure 5).
The structural overlay of SaMenH and VcMenH,
discussed above, indicates that the conserved residues in
the active site adopt similar orientations and only the
side chain of Arg174 (SaMenH numbering) differs sig-
nificantly (data not shown). In SaMenH, Arg174 is
oriented towards a5. In VcMenH, the corresponding
residue, Arg176, adopts a different rotamer and the side
chain is directed towards a1 whilst Tyr156 occupies the
site of the SaMenH Arg174 guanidinium (data not
shown). This observation suggests a degree of conforma-
tional freedom deep in the active site that might influence
the position of the cap domain.
Attempts to soak ligands such as pyruvate, salicylic
acid and the substrate SEPHCHC into crystals of
SaMenH, and so derive structures directly relevant to
substrate recognition resulted in the loss of diffraction.
Co-crystallization experiments were also carried out but
either the crystals did not grow or when available and
subsequently analyzed, there was no electron density
that could be attributed to these ligands (data not
shown). In the absence of any experimentally deter-
mined structures we sought to prepare a simple model
of the enzyme-substrate (ES) complex. We were guided
by seeking a position of SEPHCH in the active site in
which there was little steric hindrance and where the
chemical properties of substrate and active site were
complementary to each other. The potential for His243
to act as a base and acquire the C2 proton direct from
substrate was recognized. However, when the substrate
was positioned to facilitate the interaction of SEPHCH
C2 with His243 NE2 there were severe steric clashes
with the protein. The positions of the Leu155 and
Phe156 side chains in particular appear to compromise
s u c ham o d e l .W ec a n n o tr u l eo u tt h ep o s s i b i l i t yt h a t
gross structural changes might change the active site to
facilitate the use of His243 as an active site base for the
Dawson et al. BMC Structural Biology 2011, 11:19
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support such conformational changes to the catalytic
residues utilized within the a/b hydrolase family of
enzymes. An alternative model was constructed by pla-
cing SEPHCHC C2 3.3 Å from Ser89 OG. The ligand
was simply rotated about C2 to minimize steric clash
with the enzyme (Figure 6) and, as will be described, the
model suggests plausible chemical interactions to stabi-
lize the substrate in the enzyme active site.
Our ES model provides a template to consider aspects
of substrate recognition and MenH catalysis. In this we
expect that important features relevant to substrate
recognition and catalysis be conserved in MenH
sequences and the a/b-hydrolase fold as discussed
above. We noted also that the position of water mole-
cules might identify where functional groups of sub-
strate could bind. A thorough analysis, combining
kinetic studies with the use of site-directed mutagenesis
studies has been applied to seven conserved MenH resi-
dues using the E. coli enzyme (Figure 5). The kinetic
results were interpreted in light of a homology model of
EcMenH based on VcMenH combined with the use of
docking calculations [12,13]. Our SaMenH ES model
(Figure 6), which should be consistent with the kinetic
data, indeed corroborates certain aspects of the previous
study but there are significant differences in the models,
which we will detail.
Our ES model suggests that Arg127 is placed to inter-
act with the C6 hydroxyl and or the C5 carboxylate.
Lys218 could also interact with the C5 carboxylate and
Arg93 is well placed to form a salt-bridge interaction
with the C1 carboxylate. The substrate C2 carboxylate,
the succinyl substituent, is positioned in the solvent
filled channel and placed to accept hydrogen bonds
donated from Tyr88 OH and Trp150 NE1. The hydro-
phobic component, C3, C4 and the methylene group are
positioned over towards the hydrophobic patch on the
active site near Leu155 and Phe156. Mutations of the
conserved Arg93, Arg127 and Arg174 to alanine leads
to increased KM values and reduced catalytic properties.
This is compatible with a role of these arginine residues
in binding and orientating the substrate in the active
site. Arg174 does not interact with substrate in the ES
model but we cannot rule out a conformational change
that facilitates an interaction between the guanidinium
and the C2 carboxylate. The side chain of Arg174 is
implicated in positioning Trp150 and disruption of the
structure in this part of the active site might contribute
to the compromised level of enzyme activity. Asp131
interacts with Arg127 and mutation of the correspond-
ing residue, Asp128, in EcMenH to alanine leads to an
eight-fold increase in KM [13] consistent with localized
disruption to substrate binding.
The mechanism of typical a/b hydrolases involves the
formation of an oxyanion intermediate stabilized in the
active site by an “oxyanion-binding hole” usually formed
by two main chain amides. One amide is contributed
from the residue immediately following the catalytic ser-
ine, the second can vary in location but often resides on
the loop linking a b-strand and helix. Jiang et al. [13]
proposed that the oxyanion hole is located between the
side chains of Tyr88 and Trp150 (SaMenH numbering)
based on results of computational docking calculations.
This would be an extremely unusual situation not pre-
viously observed in this enzyme family. In SaMenH the
main chain amides of Met90 and Phe23 are well placed
to form the oxyanion hole; indeed a well-ordered water
molecule is observed within hydrogen bonding distance
Figure 6 A model for substrate binding to SaMenH. A stereoview of the ES complex model. SEPHCHC is depicted with C positions colored
black. MenH residues are shown as in Figure 4. Trp150 is not shown for the purpose of clarity. The chemical structure modelled represents
Stage I in Figure 7.
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Ser89 (Figure 4). A similar situation occurs in VcMenH,
with the corresponding residues being Ser91, Leu92 and
Leu24. Structural alignment with other a/b hydrolases
where the oxyanion hole has been identified support our
interpretation [26,27]. In our ES model, a carbonyl oxy-
gen of the succinyl substituent, where a negative charge
might build up, overlays on the position of this ordered
water molecule (Figure 6). That being the case we sug-
gest a different role for the conserved tryptophan
(SaMenH Trp150). Mutation of the equivalent residue
in EcMenH, Trp147 to phenylalanine, had significantly
less effect on catalysis than a Trp147 to alanine muta-
tion [13]. This further suggests that the side chain is not
actually involved in the formation of the oxyanion hole.
Our ES model suggests that Trp150 stabilizes the hydro-
p h o b i cp a r to ft h ea c t i v es i t eb yi n t e r a c t i o n sw i t h
Phe146, Phe156 and Leu153 and that Trp150 NE1, in
partnership with Tyr88 OH, donate hydrogen bonds to
bind the carboxylate of the succinyl side group of the
substrate (Figure 6). Alteration of Tyr88 to phenylala-
nine increases KM slightly but reduces catalytic effi-
ciency to a marked degree. This would support the
earlier proposal that interaction with His243 might
influence catalysis.
A proposed mechanism for MenH
All a/b hydrolases contain a catalytic triad consisting of
a nucleophile, an acid and a histidine. In many cases,
the reaction proceeds in a similar fashion to that of the
serine proteases, where the substrate is subject to
nucleophilic attack by serine, for example prolyl oligo-
peptidase [28]. The histidine and aspartate components
of the catalytic triad are essential for EcMenH activity;
mutation of the serine resulted in a considerably less
active, but still functional enzyme, suggesting a mechan-
ism distinct from most other a/b hydrolases [12,13] but
similar to the C-C bond hydrolases MhpC and BhpD.
Mutation of the active site serine in MhpC reduces but
does not abolish enzyme activity and additional kinetic
studies lead to the assignment of a general base catalysis
mechanism [29]. The non-essentiality of the active site
serine in MenH suggests that it may also adopt a gen-
eral base mechanism.
The reaction catalyzed by MenH can be described in
three stages (Figure 7). In stage I, the catalytic triad struc-
ture positions His243 to abstract a proton from Ser89
OG and so prepare a seryl oxide which in turn supports
removal of the acidic C2 proton from SEPHCHC. An
anionic intermediate is generated. Stage II is breaking the
C5-O bond to release the pyruvate side chain; a common
step in biosynthetic reactions that use chorismate. How-
ever, in most cases, the product is aromatic [30] and
MenH is unusual in generating a partially saturated pro-
duct. Nevertheless, the stability expected when a conju-
gated system is present is likely a major driving force in
pyruvate elimination from C5 subsequent to the abstrac-
tion of the proton from C2. In stage III, methylene is
reduced to the pyruvate methyl by addition of a proton
and the product then leaves the active site.
Whereas mutation of the active site serine does not
completely destroy MenH activity, alteration of the cata-
lytic His243 is catastrophic. The explanation may reside
in the combination of two factors. Firstly, the substrate
has a relatively labile acidic C2 proton irrespective of
whether a seryl oxide is nearby to acquire it or not. The
difference is in the rate of proton loss. Secondly, His243
is primed by association with Asp216 and Tyr88 to
abstract a proton from any nearby hydroxyl group or a
water molecule, which can then be passed on to reduce
the methylene to a methyl. An attraction between this
intermediate and the protonated His243 could assist a
movement of the amino acid side chain into a position
whereby donation of a proton to the methylene group is
possible.
Conclusions
The high-resolution crystal structure of SaMenH, an
a/b hydrolase, has been determined and detailed com-
parisons carried out with proteins of related fold. The
Figure 7 A proposed mechanism for MenH.
Dawson et al. BMC Structural Biology 2011, 11:19
http://www.biomedcentral.com/1472-6807/11/19
Page 8 of 11MenH active site properties complement those of the
substrate, which is negatively charged and possesses sig-
nificant hydrophobic character. The enzyme:substrate
complex has been modelled and a potential mechanism,
exploiting previously published data combining site-
directed mutagenesis with kinetic studies of EcMenH, is
proposed. The reaction may be initiated by proton
abstraction from the substrate by an activated Ser89,
part of a catalytic triad with Asp216 and His243. The
driving force for pyruvate elimination is provided by the
formation of a conjugated system. During pyruvate elim-
ination, a methylene group is converted to a methyl and
it is possible that His243 provides a proton, acquired
from Ser89 for that reduction.
Methods
Expression and purification of SaMenH
Chemicals, of the highest quality available, were sourced
from Sigma-Aldrich and VWR International except
where stated otherwise. The menH gene was amplified
by PCR from S. aureus genomic DNA (strain American
Type Culture Collection 35556) using 5’- CATATGA-
CACACTACAAGTTTTATGAAGC-3’ as the forward
primer and 5’ - GGATCCTTAGTCATTTTGCTCCTCC
-3 ’ as the reverse primer (Thermo Scientific). These
oligonucleotides contain 5’ NdeIa n d3 ’ BamHI sites
indicated in bold. The PCR product was ligated into
TOPO-BLUNT-II (Invitrogen) and then subcloned into
a modified pET15b vector (Novagen), which produces
an N-terminally hexa-histidine tagged protein with a
Tobacco Etch Virus (TEV) protease site. The resulting
expression vector was heat shock transformed into
E. coli strain BL21 (DE3) (Stratagene). Cell cultures
were grown in 1 L volumes using Luria-Bertani media
supplemented with 50 μgm L
-1 of carbenicillin at 37°C
to an optical density of 0.6. The cultures were cooled to
room temperature, expression induced using 0.5 mM
isopropyl-b-D-thiogalactopyranoside, and growth contin-
ued for 16 hours at room temperature.
Cells were harvested by centrifugation for 25 minutes
at 40,000 g at 4°C, resuspended in lysis buffer (50 mM
Tris-HCl, 250 mM NaCl, 20 mM imidazole pH 7.5) con-
taining DNase I (0.1 mg), and a single tablet of a cocktail
of EDTA-free protease inhibitors (Roche), and lysed
using a French press at 1000 psi. Insoluble debris was
separated by centrifugation at 39,000 g for 25 minutes, at
4°C. The supernatant was loaded onto a 5 mL HisTrap
HP column (GE) precharged with Ni
2+. A linear concen-
tration gradient of imidazole was applied, with SaMenH
eluting at approximately 160 mM imidazole. Fractions
were analyzed using sodium dodecyl sulfate polyacryla-
mide gel electrophoresis (SDS-PAGE), and those contain-
ing SaMenH were pooled and incubated with TEV
protease at 30°C for three hours. The untagged protein
was separated from the TEV protease, tag and residual
tagged protein using a second Ni
2+ charged HisTrap
column; the untagged protein still bound weakly to
the column, eluting at approximately 80 mM imida-
zole. The untagged SaMenH was then further purified
using a Superdex 200 26/60 gel filtration column
(GE), equilibrated using 50 mM Tris-HCl, 250 mM
NaCl pH 7.5. The protein eluted as a single species
with mass of approximately 30 kDa consistent with
that of a monomer. Selected fractions were pooled,
dialyzed into 20 mM Tris-HCl, 50 mM NaCl, pH 7.5
and concentrated for crystallization. The protein con-
centration was estimated spectrophotometrically using
a theoretical extinction coefficient of 32,890 M
-1 cm
-1
(ProtParam) [31].
Crystallization and data collection
Initial screening was performed using sitting drop vapor
diffusion with standard sparse matrix screens. Multiple
hits were obtained in conditions containing polyethylene
glycol (PEG). Further tests with a PEG screen (Qiagen)
yielded a diffraction quality crystal from reservoir condi-
tions 0.1 M sodium HEPES pH 7.5, 25% w/v PEG 4000 in
a drop consisting of 1 μL of protein solution (5 mg mL
-1 )
and 1 μL of reservoir. Rod shaped crystals took several
weeks to appear at 20°C. A crystal (approximately 0.5 ×
0.08 × 0.08 mm
3) was mounted directly from the drop,
without any additional cryoprotection, into a flow of
cooled nitrogen at -173°C. Data were collected in-house
using a Rigaku Micromax 007 rotating anode (Cu Kal=
1.5418 Å) R-AXIS IV
++ image plate system. The data
were integrated using XDS [32] and scaled with Scala
[33]. Statistics are presented in Table 1.
Structure solution and refinement
The search model for molecular replacement calculations
was derived from PDB entry 1r3d, the MenH orthologue
from V. cholerae. Non-conserved side chains were trun-
cated to alanine using Chainsaw [34], and molecular
replacement carried out in Phaser [35]. Initial rigid body
refinement gave an R-factor of 55%. Rounds of model
manipulation using Coot [36] interspersed with refine-
ment using Refmac5 [37] were used to complete the pro-
tein model; addition of water molecules then completed
the refinement. The Rwork and Rfree values converged at
18.3 and 24.1% respectively. TLS refinement using three
domains (analysis used the TLS server [38]) was included
as part of the refinement. The three domains consisted of
residues 2-45, 46-119 and 120-265. The Diffraction-com-
ponent Precision Index (DPI), as defined by Cruickshank
[39], and the Ramachandran plot statistics, as calculated
in Molprobity [40], are given in Table 1.
Dawson et al. BMC Structural Biology 2011, 11:19
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Page 9 of 11Protein Data Bank accession numbers
Coordinates and structure factors have been deposited
with accession code 2xmz.
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